From: Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis
Characteristicsa | Total (n = 250) | Survivors (n = 209) | Non-survivors (n = 41) | Estimate with 95% CIb | p valuec |
---|---|---|---|---|---|
Female gender | 116/250 (46.4%) | 97/209 (46.4%) | 19/41 (46.3%) | 1 (0.48 to 2.06) | 1 |
Aged (months) | 34.83 (6.47–108.63) | 35.5 (7.16–111.45) | 23.8 (1.43–81.97) | 3.33 (− 6.55 to 18.07) | 0.2725 |
Neonates < 1 month | 22/249 (8.8%) | 14/208 (6.7%) | 8/41 (19.5%) | 3.34 (1.12 to 9.34) | 0.0149 |
Infants 1–3 months | 24/249 (9.6%) | 20/208 (9.6%) | 4/41 (9.8%) | 1.02 (0.24 to 3.28) | 1 |
Diagnosed underlying disease | |||||
Central nervous system | 46/250 (18.4%) | 34/209 (16.3%) | 12/41 (29.3%) | 2.12 (0.89 to 4.82) | 0.075 |
Cardiovascular | 39/250 (15.6%) | 31/209 (14.8%) | 8/41 (19.5%) | 1.39 (0.51 to 3.45) | 0.4808 |
Digestive tract | 41/250 (16.4%) | 32/209 (15.3%) | 9/41 (22%) | 1.55 (0.59 to 3.74) | 0.3546 |
Respiratory system | 51/250 (20.4%) | 41/209 (19.6%) | 10/41 (24.4%) | 1.32 (0.53 to 3.05) | 0.5258 |
Oncologic | 37/250 (14.8%) | 31/209 (14.8%) | 6/41 (14.6%) | 0.98 (0.31 to 2.64) | 1 |
Kidney | 30/250 (12%) | 22/209 (10.5%) | 8/41 (19.5%) | 2.05 (0.73 to 5.31) | 0.1169 |
Liver | 18/250 (7.2%) | 15/209 (7.2%) | 3/41 (7.3%) | 1.02 (0.18 to 3.87) | 1 |
Skin | 11/250 (4.4%) | 10/209 (4.8%) | 1/41 (2.4%) | 0.5 (0.01 to 3.68) | 1 |
Other diagnosis | 30/250 (12%) | 25/209 (12%) | 5/41 (12.2%) | 1.02 (0.29 to 2.97) | 1 |